Heather D. Turner, SVP, General Counsel & Secretary at Orexigen Therapeutics, Inc. (OREX), sold 22,643 shares at $6.00 ($136K) on 2014-12-02, disclosed to the SEC on 2014-12-04.
Scheduled sale ($136k) by SVP, General Counsel & Secretary under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| OREX | SELL | 2014-11-26 | $183K | — | Filing → |
| OREX | SELL | 2014-09-22 | $1.3M | — | Filing → |
| OREX | SELL | 2012-07-19 | $633K | — | Filing → |